BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7237413)

  • 1. Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2051-5. PubMed ID: 7237413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Anderson AJ; Holcenberg JS
    Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS
    Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS; Tang E; Dolowy WC
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary control of lipogenesis in vivo in host tissues and tumors of mice bearing Ehrlich ascites carcinoma.
    Kannan R; Lyon I; Baker N
    Cancer Res; 1980 Dec; 40(12):4606-11. PubMed ID: 7438094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells.
    Carrascosa JM; Martínez P; Núñez de Castro I
    Cancer Res; 1984 Sep; 44(9):3831-5. PubMed ID: 6146402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in mRNAs for enzymes of glutamine metabolism in the tumor-bearing mouse.
    Aledo JC; de Pedro E; Gómez-Fabre PM; Núñez de Castro IN; Márquez J
    Anticancer Res; 2000; 20(3A):1463-6. PubMed ID: 10928057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc deficiency and growth of Ehrlich ascites tumor.
    Minkel DT; Dolhun PJ; Calhoun BL; Saryan LA; Petering DH
    Cancer Res; 1979 Jul; 39(7 Pt 1):2451-6. PubMed ID: 445445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of nitrogen in Ehrlich ascites tumor cells: role of glutamine and ammonium].
    Carrascosa JM; Martínez P; Núñez de Castro I
    Rev Esp Oncol; 1983; 30(4):533-7. PubMed ID: 6599917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological disposition of pentobarbital in tumor-bearing mice.
    Beck WT; Mandel HG; Fabro S
    Cancer Res; 1975 May; 35(5):1333-40. PubMed ID: 1120316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumor.
    Pain VM; Randall DP; Garlick PJ
    Cancer Res; 1984 Mar; 44(3):1054-7. PubMed ID: 6692391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of uremia on tumor growth in mice.
    Roll D; Schwartz N; Ben-Bassat J; Czaczkes JW
    Isr J Med Sci; 1978 Sep; 14(9):975-8. PubMed ID: 721426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
    Maity P; Chakraborty S; Bhattacharya P
    J Exp Clin Cancer Res; 2000 Jun; 19(2):161-4. PubMed ID: 10965812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamine metabolism in the liver of mice with Ehrlich ascites carcinoma.
    Trebukhina RV; Ostrovsky YuM ; Shapot VS; Petushok VG; Velichko MG; Tumanov VN; Mikhaltsevich GN
    Neoplasma; 1982; 29(3):257-68. PubMed ID: 6127634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of thiamine diphosphate in the liver of tumor-bearing animals kept on a diet including an excessive amount of vitamin B 1].
    Trebukhina RV; Petushok VG; Tumanov VN; Mikhal'tsevich GN
    Vopr Pitan; 1986; (1):63-5. PubMed ID: 3962272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
    Ghosh S; Roy S; Banerjee M; Maity P
    J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.